A Single Dose Comparative Bioavailability Study of Linagliptin/Metformin hydrochloride2.5mg/500mg Combination Tablets Versus Linagliptin 2.5mg Tablets Administered With Glucophage 500mg Tablets Under Fasting Conditions.
Phase of Trial: Phase I
Latest Information Update: 23 Jan 2013
At a glance
- Drugs Linagliptin/metformin (Primary) ; Linagliptin; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 23 Jan 2013 Primary endpoint amended as reported by ClinicalTrials.gov.
- 12 Jan 2012 Actual patient number (18) added as reported by ClinicalTrials.gov.
- 12 Jan 2012 Actual end date ( Dec 2011) added as reported by ClinicalTrials.gov.